Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Hospira, Inc.
483
•Hospira, Inc.•January 19, 2010

Hospira, Inc. – FDA 483, Jan 19, 2010

Record Details

During an inspection from January 12-19, 2010, at Hospira, Inc.'s medical device and drug manufacturing facility in Rocky Mount, NC, the FDA issued a Form 483 detailing significant observations. The primary issues centered on inadequate control procedures and documentation for manufacturing processes, particularly process validation. The company failed to establish validated solution tank mixing processes for products like Amridate, Amikacin, Droperidol, and heparin lock flush solutions, which could cause variability in product characteristics. Furthermore, in-process specifications were not determined using appropriate statistical methods, and critical control parameters for certain processes were not adequately identified or evaluated. Significant documentation deficiencies were also noted, including the destruction of batch records for a 2003 Heparin Lock Flush Solution mixing validation study. Moreover, quality problems, such as visible particulate found during a validation, were not properly investigated or communicated internally to prevent recurrence. These observations indicate non-compliance with the regulatory framework for manufacturing and quality control. Hospira, Inc. formally committed to correcting all identified issues.

Company
Hospira, Inc.
Inspection date
January 19, 2010
Product type
devices
Office
Atlanta District Office
People
  • Hector E. Jimenez (Site Quality Director)
  • Thomas R. Berry (Program Expert)
View Company Profile

ID · 3365c585-9a89-490b-8017-59eec2c09af5

Other documents for Hospira, Inc.
  • 483 - 2023-11-14November 14, 2023
  • 483 - 2019-11-21November 21, 2019
  • 483 - 2018-02-02February 2, 2018
  • WARNING_LETTER - 2013-11-15November 15, 2013
  • 483 - 2013-03-01March 1, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hospira, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.